Interactive modules by Olga Goodman, MD.Copyright protected · Read termsClose terms

All RheumaView™ interactive modules, quizzes and educational cases are original works developed by Olga Goodman, MD.

Without the author’s prior written permission, you may not copy or republish these modules or their components; extract, reuse or modify their original software code (“engines”); or use that code to build your own modules, quizzes or other products.

You may not claim these works as your own or remove or replace the author’s name or copyright notices. When quoting material, credit Olga Goodman, MD, identify the source and include a direct link to the original.

Free or public access is provided for learning and does not grant permission to copy, adapt or redistribute the materials. Unauthorized use of protected material may constitute copyright infringement. Exceptions and limitations provided by applicable law remain unaffected.

Sharing direct links to the modules is welcome.

© 2026 Olga Goodman, MD. All rights reserved.

The Ones Who Stopped Writing

Oct 3, 2026 · Olga Goodman, MD

Lena posted in the evenings, when her hands had loosened enough to type. Mornings belonged to the illness. “This morning: forty minutes to get into a cardigan,” she wrote. “The cardigan is winning.” Eleven women answered, “Same.”

Twice she canceled dinner with a friend, and the friend stopped asking. When her doctor suggested a new treatment, Lena read the leaflet and reported back. “Four pages of what can go wrong, one line about what it’s for. I’m scared. Won’t pretend otherwise.” A dozen women said they had been scared too.

She started the treatment anyway. The first weeks were rough, and she posted about them in the same dry voice, including a visit where her doctor listened to the whole list of complaints and changed the plan. “I came ready to be angry,” she wrote. “He ruined it.”

Then the posts spaced out until a month could pass between them. The last one was a photograph of a ferry railing against a flat gray sea, a paper cup of coffee balanced on the rail. It had no caption and three hearts, and nothing about it looked like an ending.

Lena had gone back to a life where the illness no longer took up the whole day. There was less time for the group, and less she needed to ask it.

Katarina’s story was the other kind. A few weeks into the same treatment she was admitted to the hospital with a serious complication, and she posted from the ward. First came a photograph of her wristband, then the evening it all began, down to the minute. “I was making soup,” she wrote. “I remember thinking it was just a bad day.”

Women who had never met her kept her company through the nights, and a moderator pinned the thread. Other groups copied it, with her blessing, because she wanted people to know what had happened. The complication was real and serious, and nobody suggested she had brought it on herself.

The title carried the name of the drug, so anyone who typed it into the search box landed on Katarina first, and every reply floated the thread back to the top. By spring it had six hundred comments, nearly all of them kind.

Lena’s story had no title. It was a few hundred small posts about cardigans and canceled dinners, and the only ending it had was a ferry.

Marta read the group the week before her first dose, the way you read a contract: looking for the catch. Katarina’s thread took her an evening. When she got to the ambulance she shut the laptop and walked around the kitchen, then came back and read the rest, replies included.

What she came away with was accurate as far as it went. The drug had already done serious harm to a woman with a name and a wristband. The people it had helped weren’t in the picture, because in that group a treatment that works looks like a gap in the feed. Lena’s early posts did turn up in Marta’s search, the fear and the rough first weeks. The part where it got better had never been written down. Marta never noticed that Lena was gone, and she may have scrolled right past the ferry.

The practical side got the same care. “Does anyone know if it’s okay to fly on this?” Marta asked the group. “Security, time zones, that kind of thing.” She asked her doctor too and wrote down the answer. Two years had passed since she’d been anywhere; the illness had seen to that, and she had stopped mentioning it. She only wanted to be sure the drug wouldn’t spoil a trip she had no plans to take.

The first dose was still on her shelf when Marta began to post. “I haven’t slept past four in weeks,” she wrote. “My hands, the tiredness, the stairs at my sister’s. I used to run up those.” Forty replies came in before her tea went cold, most of them some version of “you’re not alone,” and someone recommended a heating pad.

The group was good at this. What it could not give her was a different subject. If she had started the treatment and it had worked, she might have been posting about something else by now, a trip, say, or nothing in particular. Maybe. Nobody can promise that, her doctor included, and the treatment might fail or bring trouble of its own. The possibility of getting some of her life back had never become as concrete as Katarina’s hospital wristband. Katarina’s story took up all the room the decision had.

In November Lena came back for about a minute. Someone had come across her old cardigan post and asked, “Lena?? Where did you go?” “Still here!” she wrote. “Working, mostly, and I walk a lot now. Boring stuff, honestly. Thanks for asking!” It collected two hearts and a thumbs-up. By morning it had sunk below the newer posts, past the point where most readers would scroll.

Katarina’s story has to be heard, and the group was right to keep it. A person choosing a treatment also needs to hear from the ones who no longer live in the patient group. Someone has to ask them, and what they say should be as easy to find as Katarina’s thread.

Share this page

FacebookLinkedInXWhatsAppTelegram

Topics: author perspectiveCommunicationDecisiones de tratamientoDecyzje terapeutyczneБезопасность лекарствMedication safetyTreatmentTreatment decisions